Back
ESC Professional Premium Access

Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

Session: Biomarkers for heart failure 1
Topic: Biomarkers
Speaker: Doctor J. Cunningham (Boston, US)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jonathan Cunningham

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
2 followers

6 more presentations in this session

Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy

Speaker: Doctor R. Klingenberg (Bad Nauheim, DE)

Access
Abstract
Slides
Like
Thumbnail

NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Speaker: Doctor O. Wozniak (Warsaw, PL)

Access
Abstract
Slides
Like
Thumbnail

Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

Speaker: Doctor M. Iguchi (Kyoto, JP) Professor K. Hasegawa (Kyoto, JP)

Access
Abstract
Slides
Like
Thumbnail

Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure

Speaker: Doctor R. Pistulli (Munster, DE)

Access
Abstract
Slides
Like
Thumbnail

Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).

Speaker: Mr C. Kelly (Newcastle, AU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Biomarkers for heart failure 1

Speakers: Doctor J. Cunningham, Doctor R. Klingenberg, Doctor O. Wozniak, Doctor M. Iguchi, Professor K. Hasegawa...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources